Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-28 @ 1:05 PM
Study NCT ID:
NCT00086203
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2004-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Point Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-09
Completion Date Type:
None
First Submit Date:
2004-06-28
First Submit QC Date:
None
Study First Post Date:
2004-06-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-24
Last Update Post Date:
2015-03-25
Last Update Post Date Type:
ESTIMATED